tiprankstipranks
Trending News
More News >
PTC Therapeutics (PTCT)
NASDAQ:PTCT
US Market

PTC Therapeutics (PTCT) Financial Statements

Compare
406 Followers

PTC Therapeutics Financial Overview

PTC Therapeutics's market cap is currently $5.64B. The company's EPS TTM is $-1.67; its P/E ratio is 8.81; PTC Therapeutics is scheduled to report earnings on February 19, 2026, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 1.73B$ 806.78M$ 937.82M$ 698.80M$ 538.59M
Gross Profit$ 1.66B$ 749.38M$ 872.34M$ 654.12M$ 506.26M
Operating Income$ 856.51M$ -302.57M$ -439.50M$ -447.41M$ -374.44M
EBITDA$ 887.66M$ -120.46M$ -330.34M$ -367.78M$ -368.18M
Net Income$ 682.64M$ -363.30M$ -626.60M$ -559.02M$ -523.90M
Balance Sheet
Cash & Short-Term Investments$ 1.95B$ 1.14B$ 876.74M$ 410.70M$ 773.38M
Total Assets$ 2.91B$ 1.71B$ 1.90B$ 1.71B$ 1.94B
Total Debt$ 492.28M$ 2.47B$ 2.23B$ 1.46B$ 1.27B
Net Debt$ -492.37M$ 1.69B$ 1.64B$ 1.18B$ 1.08B
Total Liabilities$ 3.12B$ 2.80B$ 2.71B$ 2.05B$ 1.94B
Stockholders' Equity$ -205.31M$ -1.10B$ -818.55M$ -347.09M$ 1.44M
Cash Flow
Free Cash Flow$ 702.34M$ -181.94M$ -279.04M$ -509.11M$ -336.66M
Operating Cash Flow$ 711.20M$ -107.69M$ -158.42M$ -356.65M$ -251.33M
Investing Cash Flow$ -861.98M$ 44.18M$ -176.74M$ 290.18M$ 219.18M
Financing Cash Flow$ 331.09M$ 255.87M$ 646.40M$ 167.95M$ 20.88M
Currency in USD

PTC Therapeutics Earnings and Revenue History

PTC Therapeutics Debt to Assets

PTC Therapeutics Cash Flow

PTC Therapeutics Forecast EPS vs Actual EPS